FDA Sued by ProPublica Over Withheld Records on Generic Drug Safety
ByAinvest
Wednesday, Jun 18, 2025 5:06 am ET1min read
DMAA--
ProPublica has sued the FDA for withholding records about the safety of generic drugs critical to millions of Americans. The agency declined to release the documents, including those identifying drugs made in troubled factories in India. ProPublica requested the records as part of an ongoing investigation into the safety of America's generic drug supply. The case is still active in federal court in New York.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet